Literature DB >> 30325410

Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?

Nuria Garcia-Fernandez1,2, Javier Lavilla1,2, Paloma L Martín1,2, Gregorio Romero-González1,2, Arantxa González2,3,4, Begoña López2,3,4, Susana Ravassa2,3,4, Javier Díez1,2,3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30325410     DOI： 10.1093/ajh/hpy153

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN： 0895-7061            Impact factor:   2.689


× No keyword cloud information.
  1 in total

Review 1.  The "FIFTY SHADOWS" of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease.

Authors:  Gregorio Romero-González; Jordi Bover; Javier Arrieta; Davide Salera; Maribel Troya; Fredzzia Graterol; Pablo Ureña-Torres; Mario Cozzolino; Luca Di Lullo; Pietro E Cippà; Marina Urrutia; Javier Paúl-Martinez; Ramón Boixeda; José Luis Górriz; Jordi Ara; Antoni Bayés-Genís; Antonio Bellasi; Claudio Ronco
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.